Thursday, 28th March 2024
To guardian.ng
Search
News  

Learning the combination code of Blockchain and AI

By Guardian Nigeria
15 January 2023   |   1:50 am
To aid pharmaceutical factory workers, exoskeletons. 3D printing makes it possible for pharmacies to make drugs right away. Blockchain technologies for drug counterfeiting prevention.

blockchain

To aid pharmaceutical factory workers, exoskeletons. 3D printing makes it possible for pharmacies to make drugs right away. Blockchain technologies for drug counterfeiting prevention. Although these are mere fragments, disruptive technologies will have an impact on the pharmaceutical supply chain as a whole. Let me show you how new technologies will make it faster, cheaper, and more effective than ever.

Every day, the robot saves humans approximately two hours of stacking and distributing medication. Additionally, it only makes mistakes if we do. Pharmacies can cut down on waiting time and time spent on repetitive tasks by using robotic tools. This is just one small example of the many other ways robots can help the pharmaceutical supply chain.

The Future of Pharmacies

Will Pharmacies of the Future Employ Robots Behind the Counter? Probably. However, a human will also be present. The pharmaceutical supply chain relies heavily on speed and efficiency. Its main goal is to get the right medicine to the person in need as soon as possible so they can get better as quickly as possible. Even though new technologies have been constantly altering the drug design, manufacturing, and distribution supply chains, the scope and quality of the most recent transformation are significantly greater.

Second, the expansion of transportation, new technologies, and globalization have all contributed significantly to the scope and complexity of these networks. Thirdly, these networks will become more fragmented and diverse as a result of personalization and targeted treatments, and fourthly, disruption will make it possible for smaller businesses with fewer experiences to connect with the market.

In addition, there is a real possibility that, as a result of 3D printing or artificial intelligence, the patient’s home will also become a part of the supply chain. Obviously, each technology will have a different effect on a different part of the pharmaceutical supply chain, so it’s worth looking at each one separately and in greater detail.

A.I. Solutions in Drug Design

Artificial intelligence (AI) solutions have the potential to fundamentally alter the conventional method of drug design. It might make the development of drugs much less expensive and more effective; significantly reducing the time it takes to make a drug and assisting the pharmaceutical industry in finding new drugs.

According to estimates, it takes an experimental drug approximately 12 years and $2.9 billion to go from concept to market. In 2019, the artificial intelligence-based pharmaceutical startup Insilico Medicine found a new drug in just 46 days. This is what AI can do differently. Atomwise, based in San Francisco, makes use of supercomputers to select treatments from a database of molecular structures.


AI Algorithm in Ebola Outbreak

Atomwise utilized its artificial intelligence (AI) algorithm during the 2015 Ebola outbreak to identify two medications with significant potential to lessen Ebola infection. This analysis, which would normally take months or years to complete, was finished in less than a day. To aid in the search for effective COVID-19 drug treatments, global cooperation was established at the beginning of the pandemic. BarabasiLab had a list of promising drugs that could be tested in human cell lines in an experimental laboratory in less than ten days after repurposing their toolset to find a treatment for COVID-19.

Network Medicine

Network medicine based on artificial intelligence enabled them to do so. Network medicine will support drug manufacturing with robotics and augmented reality. Arguments in favor of robots include consistency and efficiency in terms of costs. because the robot does everything it is told to do and everything it does can be documented in detail.

For instance, the cartesian, SCARA, and articulated robots offered by Denso Robotics, a global robotics company, can be used for a variety of pharmaceutical manufacturing tasks. Additionally, creating these robots with robust data mining capabilities is an emerging best practice. This indicates that pharmacies can constantly gain useful insights regarding their traffic and effectiveness.

When it comes to more difficult tasks that call for creative thinking and the ability to solve problems, humans cannot and will not be replaced by robots or artificial intelligence. However, digital technologies can help humans become better at their jobs.

Augmented Reality

Using augmented reality (AR) to help people learn faster and more effectively is one example in the pharmaceutical industry. Furthermore, additional staff would not be required for their training; Colleagues tasked with training newcomers might be given different responsibilities. Exoskeletons could also help workers lift heavy objects and keep them seated or in other uncomfortable positions for long periods of time.

Other Production Options
3D printing drugs in pharmacies. While automation and augmented reality-supported workforce significantly accelerate the manufacturing process and make it possible to produce large quantities of the same medication, 3D printing would enable pharmaceutical companies to produce drugs in dose formats that are more effective. Personalized medicine and low-volume production would also be possible as a result of this.

Spritam

A 3D-printed medication for epilepsy, received FDA approval in 2016. The powdered drug is printed out layer by layer, causing it to dissolve more quickly than standard pills. Spritam, on the other hand, is the only 3D-printed medication that has been approved by the FDA thus far. Dr. Alvaro Goyanes, Development Director and lead project researcher for the 3D printed drug company FabRx, disclosed the following in an exclusive interview with The Medical Futurist Patreon channel: We envision a system in which medicines will be made from raw materials in the same way that coffee is made in a Nespresso machine. However, the FabRx team was wary of the possibility that the patient could 3D print their own prescription by emailing it to their general practitioner.


Distribution chains protected by blockchain technology

The most significant obstacle in the chain of distribution—from pharmaceutical companies to hospitals, pharmacies, and distributors—is ensuring the security and safety of the products themselves. As the negative effect of globalization and networked markets, counterfeit medicine has become a pressing issue; both in terms of the financial burden that this global black market places on individuals and the danger that counterfeit drugs pose to human life. Between 10 and 30 percent of all medicines sold in many developing nations in Asia, Africa, and South America are fakes.

Conclusion

Blockchain technology may provide a solution to this problem. Through its transparency, the technology provides safety. Patients at the far end of the supply chain, as well as authorized parties, are able to view this ongoing real-time record at any time. Criminal organizations would find it much more challenging to market counterfeit drugs as a result of this. However, blockchain’s benefits for the pharmaceutical industry do not end there. Check bitcoineranew.com for more uses. Despite the fact that the digital currencies demanded by attacks are supported by blockchain, the technology may also be useful in protecting sensitive industry data from malicious attacks.

In this article

0 Comments